Table 3.
Characteristic | Placebo (group A; n = 31) | Omega-3 (group B; n = 33) |
---|---|---|
Sex | ||
Male, n (%) | 9 (29.03) | 9 (27.2) |
Female, n (%) | 22 (70.97) | 24 (72.8) |
Age in years, mean | 54 | 58 |
Signs | ||
Lid margin inflammation severity, n (%) | ||
No injection | 9 (29.03) | 10 (30.3) |
Injection | 22 (70.97) | 23 (69.7) |
Meibomian gland secretion, n (%) | ||
Clear fluid | 1 (3.22) | 4 (12.12) |
Cloudy fluid | 21 (67.74) | 20 (60.60) |
Cloudy particulate fluid | 6 (19.35) | 8 (24.24) |
Inspissated, like toothpaste | 3 (9.68) | 1 (3.03) |
No secretion | 0 | 0 |
Mean TBUT (SD), s | 6.45 (2.57) | 6.94 (2.75) |
Mean Schirmer I (SD), mm | 16.61 (7.57) | 18.94 (7.47) |
Cornea staining data. Oxford test, n (%) | ||
Grade 0 | 23 (74.2) | 22 (66.7) |
Grade I | 5 (16.1) | 11 (33.3) |
Grade II to IV | 3 (9.7) | 0 (0) |
Symptoms | ||
OSDI© | ||
Normal | 2 | 0 |
Mild | 7 | 4 |
Moderate | 12 | 17 |
Severe | 10 | 12 |
Abbreviations: OSDI©, Ocular Surface Disease Index; SD, standard deviation; TBUT, tear breakup time; s, seconds.